JP Morgan Maintains Overweight on Merck & Co, Raises Price Target to $175
Benzinga Newsdesk 13 hours ago
Analyst RatingsNewsPrice TargetHot
JP Morgan analyst Chris Schott maintains Merck & Co (NYSE:MRK) with a Overweight and raises the price target from $165 to $175.
JP Morgan analyst Chris Schott maintains Merck & Co (NYSE:MRK) with a Overweight and raises the price target from $165 to $175.